Omega Therapeutics IPO Presentation Deck
A world-class management team to deliver on our vision
Mahesh Karande
President & CEO
NOVARTIS
McKinsey
& Company
Roger Sawhney
CFO
NOVARTIS
BAIN
COMPANY
MACROLIDE
ARMACEUTICALE
Ⓒ2021 Omega Therapeutics, Inc.
Leadership
BCG
KKR
Thomas McCauley
CSO
Shire Translate BIO
RONA
Archemix
Joe Newman
VP, Biology
Zıkanı AstraZeneca
Founded by Flagship Pioneering
Noubar Afeyan
Chairman & Founder
Q:
David Berry
Founder
XX
Noubar Afeyan
Co-Founder Chairman
Flagship, Founder & CEO
John Mendlein
Executive Partner, Flagship
Founding Scientific Advisors
MIT & Whitehead Institute
Rudolf Jaenisch
Richard A. Young
Board of Directors
David Berry
Co-Founder
Flagship, General Partner
Mary Szela
TrisalusLife Sciences, CEO
Rick Young
MIT, Professor of Biology:
Whitehead Institute, Member
Elliott Levy
Amgen, BMS
Luke Beshar
NPS Pharma
12View entire presentation